CDKN2A/B rs10811661: What Your Genotype Means
The rs10811661 variant is a common genetic polymorphism located in the region upstream of the CDKN2A and CDKN2B genes. It has been widely studied for its statistical association with an increased susceptibility to type 2 diabetes and potential impacts on pancreatic beta-cell function.
What each genotype means
Baseline diabetes risk
This genotype is considered the baseline or reference state for this variant. Research indicates that individuals with this genotype do not carry the specific T-allele associated with increased susceptibility to type 2 diabetes in various populations.
This genotype is common, though its exact frequency varies significantly across different global ancestral populations.
Increased diabetes risk
Carrying one copy of the T-allele is associated with a statistically significant increase in the risk of developing type 2 diabetes compared to those without the allele. Studies suggest this variant may influence pancreatic beta-cell function, potentially leading to impaired insulin release in response to glucose.
This heterozygous genotype is frequently observed in many populations, with the T-allele being a well-documented risk factor in large-scale genome-wide association studies.
Elevated diabetes risk
Individuals with two copies of the T-allele show an increased susceptibility to type 2 diabetes and may exhibit adverse metabolic traits, such as altered insulin resistance or impaired insulin secretion. Research has linked this genotype to higher risks in multiple ethnic groups, though the absolute risk is influenced by a combination of genetic and lifestyle factors.
This homozygous genotype is found in a substantial portion of the population, with frequencies varying by ancestry.
Understanding the rs10811661 Variant
The rs10811661 variant is a single nucleotide polymorphism (SNP) situated in the genomic region upstream of the CDKN2A and CDKN2B genes. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. Because this variant is located in a non-coding regulatory region, it is thought to influence the expression levels of nearby genes rather than altering the structure of a protein directly. Researchers track this specific location because it has consistently appeared in genome-wide association studies (GWAS) as a marker linked to metabolic health traits. While the variant itself is just a single letter change in the vast human genome, its presence is used by scientists to investigate the complex genetic architecture that contributes to how the body manages blood glucose levels and insulin production.
The Role of CDKN2A and CDKN2B
The CDKN2A and CDKN2B genes are primarily known for their role in regulating the cell cycle, acting as tumor suppressors that prevent uncontrolled cell division. However, in the context of metabolic health, these genes are also expressed in the pancreas. Specifically, they are involved in the regulation and regeneration of pancreatic beta cells, which are the specialized cells responsible for producing and secreting insulin. Insulin is the hormone essential for maintaining healthy blood sugar levels. When the function or regulation of these genes is altered, it may impact the ability of the pancreas to secrete sufficient insulin in response to glucose. This biological pathway is why researchers focus on the region surrounding these genes when studying the genetic components of type 2 diabetes, as impaired beta-cell function is a hallmark of the condition.
Research and Statistical Associations
Numerous studies have investigated the link between rs10811661 and type 2 diabetes. Meta-analyses of large cohorts have frequently identified the T allele as being associated with a higher risk of developing type 2 diabetes compared to the C allele. Research suggests this may be due to reduced insulin secretion and impaired glucose tolerance in carriers of the risk-associated genotype. However, the evidence is not universal; some studies, such as those conducted in specific populations like the Czech Slavonic group, have reported no significant association, highlighting that genetic risk factors can vary significantly across different ancestries and environments. Because the effect size of this variant is relatively modest, it is considered a contributor to overall risk rather than a direct cause. It is important to note that these findings are based on statistical correlations in large groups and cannot predict an individual's health outcome.
Population Frequency
The rs10811661 variant is considered a common polymorphism, meaning it is found frequently across many different human populations. The minor allele frequency typically ranges between 0.40 and 0.45, indicating that both the C and T alleles are widely distributed globally. Because it is so common, a large portion of the general population carries at least one copy of the risk-associated allele. This high frequency is why it is often identified in large-scale genetic studies, as there is ample data available to perform statistical comparisons. While the frequency is high, the actual impact on an individual's health remains a subject of ongoing research, as the presence of the allele does not guarantee the development of any specific condition.
Interpreting Your Genetic Information
If you have access to your genetic data regarding rs10811661, it is important to view this information as a small piece of a much larger puzzle. Genetic predisposition is only one factor in metabolic health; lifestyle choices, such as diet, physical activity, and weight management, play a significant role in the development of type 2 diabetes. You cannot use this information to diagnose yourself or predict your future health. If you are concerned about your risk for diabetes, the most effective approach is to consult with a healthcare professional. They can evaluate your family history, clinical blood markers, and overall lifestyle to provide personalized guidance. Never make changes to your health regimen or medication based solely on genetic reports without first discussing them with your doctor or a qualified medical provider.
How common is this variant?
The rs10811661 variant is common, with a minor allele frequency typically observed between 0.40 and 0.45 across diverse global populations.
Frequently asked questions
Does having the T/T genotype mean I will get diabetes?
No. Genetic variants like rs10811661 only indicate a statistical association with risk, not a certainty. Many people with the T/T genotype do not develop diabetes, and many people without it do.
Can I change my risk associated with this SNP?
While you cannot change your DNA, you can influence your overall health risk through lifestyle factors. Maintaining a balanced diet, regular exercise, and routine medical check-ups are the most effective ways to manage your health regardless of your genotype.
Is this variant used for clinical diagnosis?
No. This variant is currently used primarily in research settings to understand the biological mechanisms of diabetes. It is not used as a diagnostic tool in clinical practice.
Why do some studies show different results for this SNP?
Genetic associations can vary due to differences in study design, the ancestry of the participants, and environmental factors. This is common in complex diseases like diabetes, which are influenced by many genes and lifestyle factors.
Sources & further reading
Educational information only, last refreshed 10/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10811661?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2A
Non-coding regulatory variant in the 9p21.3 tumor suppressor locus associated with susceptibility to cutaneous melanoma and vascular phenotypes.
Variant in the CDKN2A/B locus associated with Type 2 Diabetes risk.
This variant is significantly associated with chronic lymphocytic leukemia risk and influences immune response pathways.